FDA official logo
GSRS logoPFDA official logo

VOBRAMITAMAB TAVATECAN

UNII:6CAR6LS9JU
Type:INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:VOBRAMITAMAB TAVATECAN
GSRS Full Record:
6CAR6LS9JU
i

  • 3036552-56-1
  • Immunoglobulin G1, anti-(human B7 homolog 3 protein) (human-Mus musculus monoclonal PRCA157 γ1-chain), disulfide with human-Mus musculus monoclonal PRCA157 κ-chain, dimer, 297,297′-bis[N-[2-(acetylamino)-4-O-[2-(acetylamino)-6-azido-2,6-dideoxy-β-D-galactopyranosyl]-2-deoxy-6-O-R-β-D-glucopyranosyl]-L-asparagine], where R = (H or 6-deoxy-α-L-galactopyranosyl), click reaction product with 1,1′-[[[[[13-(1α,8α,9β)-bicyclo[6.1.0]non-4-yn-9-yl-9,9-dioxido-1,11-dioxo-2,5,12-trioxa-9-thia-8,10-diazatridec-1-yl]amino]sulfonyl]imino]bis(2,1-ethanediyloxycarbonyl)]bis[L-valyl-N-[4-[[[[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-1-yl]amino]carbonyl]oxy]methyl]phenyl]-L-alaninamide]
  • Vobramitamab Tavatecan
  • immunoglobulin G1-kappa, anti-[Homo sapiens CD276 (B7H3, B7-H3, B7-related protein 2, B7RP2, B7RP-2, B7 homolog 3, B7 homologue 3)], humanized monoclonal antibody; conjugated to the the camptothecin derivative exatecan via a linker (vobramitamab tavatecan)
  • vobramitamab tavatecan [INN]




UNII - 6CAR6LS9JU | UNII Search Service